STING1 and neoplasm: In this setting, where STING is functional in the host antigen presenting cells, ADU-S100 alone resulted in tumor control compared to 5AZADC or vehicle treated controls; however, combination therapy was more effective in inhibiting the tumor growth in both B16-F10 and Yumm1.7 models (Fig. 8b, c).